Abstract
BackgroundTumor mutational burden (TMB) is a significant predictor of immune checkpoint inhibitors (ICIs) efficacy. This study investigated the correlation between deep learning radiomic biomarker and TMB, including its predictive value...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have